A metabolically engineered bacterium controls autoimmunity and inflammation by remodeling the pro-inflammatory microenvironment

Immunotherapy has led to impressive advances in the treatment of autoimmune and pro-inflammatory disorders; yet, its clinical outcomes remain limited by a variety of factors including the pro-inflammatory microenvironment (IME). Discovering effective immunomodulatory agents, and the mechanisms by wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Jugal Kishore, Guo, Fengguang, Hunt, Carrie, Steinmeyer, Shelby, Plocica, Julia A, Kobayashi, Koichi S., Ding, Yufang, Jayaraman, Arul, Ficht, Thomas A, Alaniz, Robert C., de Figueiredo, Paul, Song, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683044/
https://www.ncbi.nlm.nih.gov/pubmed/36404471
http://dx.doi.org/10.1080/19490976.2022.2143222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683044/
https://www.ncbi.nlm.nih.gov/pubmed/36404471
http://dx.doi.org/10.1080/19490976.2022.2143222

Ejemplares similares